Auris Medical   Report issue

Contributed to NME For profit Phase 2 Phase 3
Founded: Basel Switzerland (2003)
Status: Acquired by Johnson and Johnson (2019)

Organization Overview

First Clinical Trial
2008
NCT00802425
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Auris Medical AG | Auris Medical, Inc.